Literature DB >> 12106873

Characterization of the dihydroorotate dehydrogenase as a soluble fumarate reductase in Trypanosoma cruzi.

Eizo Takashima1, Daniel Ken Inaoka, Arihiro Osanai, Takeshi Nara, Masao Odaka, Takashi Aoki, Kozi Inaka, Shigeharu Harada, Kiyoshi Kita.   

Abstract

Trypanosoma cruzi, a protozoan causing Chagas' disease, excretes a considerable amount of succinate even though it uses the TCA cycle and the aerobic respiratory chain. For this reason, it was believed that unknown metabolic pathways participate in succinate production in this parasite. In the present study, we examined the molecular properties of dihydroorotate dehydrogenase (DHOD), the fourth enzyme of de novo pyrimidine biosynthetic pathway, as a soluble fumarate reductase (FRD) because our sequence analysis of pyr genes cluster showed that the amino acid sequence of T. cruzi DHOD is quite similar to that of type 1A DHOD of Saccharomyces cerevisiae, an enzyme that uses fumarate as an electron acceptor and produces succinate. Biochemical analyses of the cytosolic enzyme purified from the parasite and of the recombinant enzyme revealed that T. cruzi DHOD has methylviologen-fumarate reductase (MV-FRD) activity. In addition, T. cruzi DHOD was found to catalyze electron transfer from dihydroorotate to fumarate by a ping-pong Bi-Bi mechanism. The recombinant enzyme contained FMN as a prosthetic group. Dynamic light scattering analysis indicated that T. cruzi DHOD is a homodimer. These results clearly indicated that the cytosolic MV-FRD is attributable to T. cruzi DHOD. The DHOD may play an important role in succinate/fumarate metabolism as well as de novo pyrimidine biosynthesis in T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106873     DOI: 10.1016/s0166-6851(02)00100-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  18 in total

1.  Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate.

Authors:  Daniel Ken Inaoka; Eizo Takashima; Arihiro Osanai; Hironari Shimizu; Takeshi Nara; Takashi Aoki; Shigeharu Harada; Kiyoshi Kita
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-13

2.  Novel mitochondrial complex II isolated from Trypanosoma cruzi is composed of 12 peptides including a heterodimeric Ip subunit.

Authors:  Jorge Morales; Tatsushi Mogi; Shigeru Mineki; Eizo Takashima; Reiko Mineki; Hiroko Hirawake; Kimitoshi Sakamoto; Satoshi Omura; Kiyoshi Kita
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

3.  Recombinant production, crystallization and crystal structure determination of dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis.

Authors:  Renata Almeida Garcia Reis; Eder Lorenzato; Valeria Cristina Silva; Maria Cristina Nonato
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-21       Impact factor: 1.056

Review 4.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

5.  Expression of a metagenome-derived fumarate reductase from marine microorganisms and its characterization.

Authors:  Chengjian Jiang; Yu Liu; Can Meng; Lanlan Wu; Jie Huang; Jie Deng; Jinyi Wang; Peihong Shen; Bo Wu
Journal:  Folia Microbiol (Praha)       Date:  2013-05-11       Impact factor: 2.099

6.  The origin of dihydroorotate dehydrogenase genes of kinetoplastids, with special reference to their biological significance and adaptation to anaerobic, parasitic conditions.

Authors:  Takeshi Annoura; Takeshi Nara; Takashi Makiuchi; Tetsuo Hashimoto; Takashi Aoki
Journal:  J Mol Evol       Date:  2005-01       Impact factor: 2.395

7.  Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase.

Authors:  Sheila G Couto; M Cristina Nonato; Antonio J Costa-Filho
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

8.  Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.

Authors:  Elke Zameitat; Gerald Freymark; Cornelia D Dietz; Monika Löffler; Michael Bölker
Journal:  Appl Environ Microbiol       Date:  2007-03-16       Impact factor: 4.792

9.  Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.

Authors:  Tracy L Arakaki; Frederick S Buckner; J Robert Gillespie; Nicholas A Malmquist; Margaret A Phillips; Oleksandr Kalyuzhniy; Joseph R Luft; George T Detitta; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Ethan A Merritt
Journal:  Mol Microbiol       Date:  2008-02-26       Impact factor: 3.501

10.  The RNA-binding protein TbDRBD3 regulates the stability of a specific subset of mRNAs in trypanosomes.

Authors:  Antonio M Estévez
Journal:  Nucleic Acids Res       Date:  2008-07-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.